Increased Levels of Circulating Endothelial Progenitor Cells in Patients With Moyamoya Disease
Author(s) -
Neysan Rafat,
Grietje Beck,
Pablo Gerardo Peña-Tapia,
Peter Schmiedek,
Peter Vajkoczy
Publication year - 2008
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.108.529420
Subject(s) - medicine , arteriogenesis , progenitor cell , angiogenesis , endothelial progenitor cell , vascular endothelial growth factor , moyamoya disease , cd34 , endothelial stem cell , vasculogenesis , immunology , pathology , endocrinology , stem cell , biology , in vitro , biochemistry , vegf receptors , genetics
Chronic cerebral ischemia leads to higher risk for strokes attributable to insufficient collateralization, resulting from inadequate capacity for arteriogenesis and angiogenesis. Patients with Moyamoya disease (MMD) have similar transient ischemic attack frequencies compared to patients with chronic cerebral ischemia with other etiologies, but a strong capacity for arteriogenesis and angiogenesis. The mechanisms involved in the upregulation of the arteriogenesis and angiogenesis in MMD still remain unknown. In the present study we investigated if circulating endothelial progenitor cells are increasingly mobilized during MMD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom